Floatz logo

Acetazolamide

Substance-Related Disorder

University of California, San DiegoSmall moleculePhase 2Active
B
56/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
41/ 100
Competitive Position
89/ 100

Competitive context

23 Active assets in the Substance-Related Disorder cohort.

Asset / SponsorPhaseRating
METHADONE
Rutgers, The State University of New Jersey
Phase 4BBB
HYDROMORPHON
Endeavor Health
Phase 4BBB
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
Wake Forest University Health Sciences
Phase 4BBB
FENTANYL
University of Crete
Phase 4BB
Bxcl501
Kaohsiung Veterans General Hospital.
Phase 4BB

View all 26 →

Same molecule, other indications

Acetazolamide is also rated in:

Obstructive Sleep ApneaDormant
BB
Indicative ·
67 / 100
View asset →
Metabolic AlkalosisDormant
B
Indicative ·
60 / 100
View asset →
Obesity Hypoventilation SyndromeDormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →